The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
Catherine E. Winbanks(Baker Heart and Diabetes Institute), Paul Gregorevic(The University of Melbourne), Bianca C. Bernardo(Deakin University), Hongwei Qian(Baker Heart and Diabetes Institute), Justin L. Chen(Baker Heart and Diabetes Institute), Kevin I. Watt(Royal Children's Hospital), Julie R. McMullen(Baker Heart and Diabetes Institute), Lars Larsson(Boston University), Bradley J. Turner(The University of Melbourne), Craig A. Harrison(Discovery Institute), Timothy Connor(Deakin University), Yingying Liu(Shanghai University of Traditional Chinese Medicine), Rachel E. Thomson(Baker Heart and Diabetes Institute), Claudia Beyer(Baker Heart and Diabetes Institute)
Cited by 12
Related Papers
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
Extracellular Vesicles Provide a Means for Tissue Crosstalk during Exercise
|Cell Metabolism|2018|678
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
|Nature Medicine|2004|611
Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest
|Proceedings of the National Academy of Sciences|2017|482
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
|The Journal of Cell Biology|2013|222